Abstract: Thiuram sulfides of oxazolidines and thiazolidines are disclosed herein and shown to be useful as non-blooming accelerators in the vulcanization of ethylene-propylene-diene-terpolymers.

Abstract: Ethereally substituted monosaccharides are prepared from certain selectively derivatized monosaccharides. In practicing the method:1. a monosaccharide derivative having the general formula A.sub.1 -O-H, wherein O is oxygen, H is hydrogen and A.sub.

Abstract: A composite reinforced with polycrystalline alumina fibers in a matrix of an aluminum alloy containing 0.5-5.5% by weight of the matrix of lithium is prepared by infiltrating alumina fibers with a molten alloy containing aluminum and 1-8% by weight of lithium for a time sufficient to form a reaction sheath on the fibers of a thickness less than about 15% of the total fiber diameter.

Abstract: The invention provides a novel therapeutic composition comprising a pharmaceutically acceptable carrier containing a therapeutically effective amount of an ethereal monosubstitution of a monosaccharide derivative having the general formula S-O-Y, wherein S is the residue of the monosaccharide derivative selected from the group consisting of pentoses, hexoses and heptoses as single or polysubstituted acetals, ketals or esters and Y is selected from the group consisting of cyclic monovalent nitrogen-containing organic radicals and residua and monovalent organic radicals and residua having the general formula ##STR1## wherein R.sub.1 is a divalent organic radical having a linear carbon chain length of about 1-7 carbon atoms and R.sub.2 and R.sub.3 are selected from the group consisting of --H, --OH, --SH; halogen and monovalent organic radicals and residua having a linear carbon chain length of about 1-7 carbon atoms.

Abstract: The invention provides a novel therapeutic composition comprising a pharmaceutically acceptable carrier containing a therapeutically effective amount of an ethereally monosubstituted monosaccharide having the general formula S--O--Y, wherein S is the residue of a monosaccharide selected from the group consisting of pentoses, hexoses and heptoses and Y is selected from the group consisting of cyclic monovalent nitrogen containing organic radicals and residua and monovalent organic radicals and residua having the general formula ##STR1## wherein R.sub.1 is a divalent organic radical having a linear carbon chain length of about 1-7 carbon atoms and R.sub.2 and R.sub.3 are selected from the group consisting of --H, --OH, --SH, halogen and monovalent organic radicals and residua having a linear carbon chain length of about 1-7 carbon atoms. The invention also provides certain novel ethereally monosubstituted monosaccharides, of which 3--O--3'-(N',N'-dimethylamino-n-propyl)-D-glucose is an example.

Abstract: A composite reinforced with polycrystalline alumina fibers in a matrix of an aluminum alloy containing 0.5-5.5% by weight of the matrix of lithium is prepared by infiltrating alumina fibers with a molten alloy containing aluminum and 1-8% by weight of lithium for a time sufficient to form a reaction sheath on the fibers of a thickness less than about 15% of the total fiber diameter.

Abstract: Oxazolidine and thiazolidine carbodithioates of sodium, potassium and specified alkyl substituted ammonium which are useful as vulcanization accelerators for EPDM elastomers while demonstrating non-blooming characteristics.

Abstract: Oxazolidine and thiazolidinecarbodithioates, and pyridine adducts thereof, are accelerators for the vulcanization of EPDM elastomers, wherein they exhibit non-blooming characteristics.

Abstract: Oxazolidine and thiazolidinecarbodithioates, and pyridine adducts thereof, are accelerators for the vulcanization of EPDM elastomers, wherein they exhibit non-blooming characteristics.

Abstract: The present invention provides a novel method of enhancing learning and/or memory in warm blooded animals. This is accomplished by administering an effective amount to enhance the ability of the animal to learn tasks, or to enhance the ability of the animal to memorize information of at least one ethereally monosubstituted monosaccharide having the general formula S.sub.1 --O--Y, and/or at least one ethereal monosubstitution of monosaccharide derivatives having the general formula S.sub.2 -- O--Y, and/or organic acid and inorganic acid salts thereof as defined hereinafter. The warm blooded animal is subjected to an environment wherein it is required to learn tasks and/or memorize information and it is capable of learning tasks and memorizing informaton at markedly increased rates.

Abstract: Oxazolidine and thiazolidinecarbodithioates, and pyridine adducts thereof, are accelerators for the vulcanization of EPDM elastomers, wherein they exhibit non-blooming characteristics.

Abstract: Rutile TiO.sub.2 is coated successively with precipitates of titania and alumina, the weight ratio of titania:alumina being about 0.5:1 to 1:1 and the total percentage of titania and alumina being about 7 to 8%, based on the weight of said rutile TiO.sub.2. The pigment is especially suited for use in industrial paints, e.g., automotive and appliance coatings, which are based on water reducible systems.

Abstract: The invention provides a novel therapeutic composition comprising a pharmaceutically acceptable carrier containing a therapeutically effective amount of an ethereally monosubstituted monosaccharide having the general formula S-O-Y, wherein S is the residue of a monosaccharide selected from the group consisting of pentoses, hexoses and heptoses and Y is selected from the group consisting of cyclic monovalent nitrogen containing organic radicals and residua and monovalent organic radicals and residua having the general formula ##EQU1## wherein R.sub.1 is a divalent organic radical having a linear carbon chain length of about 1-7 carbon atoms and R.sub.2 and R.sub.3 are selected from the group consisting of --H, --OH, --SH, halogen and monovalent organic radicals and residua having a linear carbon chain length of about 1-7 carbon atoms. The invention also provides certain novel ethereally monosubstituted monosaccharides, of which 3-O-3'-(N',N'-dimethylamino-n-propyl)-D-glucose is an example.

Abstract: The invention provides a novel therapeutic composition comprising a pharmaceutically acceptable carrier containing a therapeutically effective amount of an ethereal monosubstitution of a monosaccharide derivative having the general formula S--O--Y, wherein S is the residue of the monosaccharide derivative selected from the group consisting of pentoses, hexoses and heptoses as single or polysubstituted acetals, ketals or esters and Y is selected from the group consisting of cyclic monovalent nitrogen-containing organic radicals and residua and monovalent organic radicals and residua having the general formula ##EQU1## wherein R.sub.1 is a divalent organic radical having a linear carbon chain length of about 1-7 carbon atoms and R.sub.2 and R.sub.3 are selected from the group consisting of --H, --OH, --SH, halogen and monovalent organic radicals and residua having a linear carbon chain length of about 1-7 carbon atoms.